BrightGene Bio-Medical Technology Co., Ltd. (SHA: 688166)
China
· Delayed Price · Currency is CNY 30.20
+0.54 (1.82%)
Jan 6, 2025, 4:00 PM CST
BrightGene Bio-Medical Technology Revenue
BrightGene Bio-Medical Technology had revenue of 319.14M CNY in the quarter ending September 30, 2024, a decrease of -2.52%. This brings the company's revenue in the last twelve months to 1.24B, up 7.03% year-over-year. In the year 2023, BrightGene Bio-Medical Technology had annual revenue of 1.18B with 15.94% growth.
Revenue (ttm)
1.24B
Revenue Growth
+7.03%
P/S Ratio
9.89
Revenue / Employee
1.07M
Employees
1,155
Market Cap
12.37B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Shanghai United Imaging Healthcare | 10.93B |
| Beijing Wantai Biological Pharmacy Enterprise | 2.49B |